Ping An has contributed to a series A round for Prenetics, which develops DNA testing technology to help deliver more accurate diagnoses.
China-based biotechnology company Prenetics has raised $10m in a series A round backed by Ping An Ventures, the corporate venturing subsidiary of insurance provider Ping An, TechCrunch reported today.
The round was also supported by Venturra Capital, a venture capital firm that raised a $150m fund in October 2015 backed by diversified conglomerate Lippo Group, as well as 500 Startups, Coent Venture Partners and Capital Union Investments.
Prenetics, spun out of City University of Hong Kong in 2009 as Multigene,…
